Skip to main content
. 2019 Sep 19;2019(9):CD000400. doi: 10.1002/14651858.CD000400.pub4

Comparison 2. NSAIDs versus tranexamic acid.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Menstrual blood loss (MBL) (mL/cycle) 1 48 Mean Difference (IV, Fixed, 95% CI) 73.0 [21.66, 124.34]
2 Proportion with no subjective improvement in MBL 1 49 Peto Odds Ratio (Peto, Fixed, 95% CI) 1.44 [0.45, 4.61]
3 Number of days' bleeding 1 49 Mean Difference (IV, Fixed, 95% CI) 0.40 [‐0.47, 1.27]
4 Proportion with no improvement in quality of life or dysmenorrhoea (or both) 1 49 Peto Odds Ratio (Peto, Fixed, 95% CI) 1.13 [0.27, 4.73]
5 Proportion who found treatment unacceptable 1 49 Peto Odds Ratio (Peto, Fixed, 95% CI) 1.17 [0.32, 4.27]
6 MBL and other outcomes (descriptive results)     Other data No numeric data